Pharmacists Controlled Substances Regulatory Guide And Compliance Manual
Download Pharmacists Controlled Substances Regulatory Guide And Compliance Manual full books in PDF, epub, and Kindle. Read online free Pharmacists Controlled Substances Regulatory Guide And Compliance Manual ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Pharmaceutical and Medical Device Compliance Manual
| Author | : Ela Bochenek |
| Publisher | : |
| Total Pages | : 319 |
| Release | : 2019 |
| Genre | : Drugs |
| ISBN | : 9781522178026 |
A robust compliance program is essential to protecting a company from running afoul of the myriad laws and regulations that have been enacted to combat fraud and waste. The second edition of the Pharmaceutical and Medical Device Compliance Manual includes guidance to help companies develop a compliance program tailored to today's complex enforcement and business environment. Study of this Manual will enable compliance professionals and lawyers to understand the government's expectations of an effective compliance program and ethical business practices, as well as: how the government discovers potential enforcement actions, its approach to pursuing such actions, what behaviors can constitute mitigating factors for a company in the event of a legal violation. Coverage includes new chapters covering:Pharmaceutical industry interactions with patient organizations Compliance 2.0: compliance analytics in the era of big dataThe art and science of health care compliance in the pharmaceutical and medical device industries The Manual will be a great tool for health and life sciences attorneys, compliance officers, and others in the pharmaceutical and medical devices industry
Pharmacist's Manual: An Informational Outline of the Controlled Substances Act
| Author | : U.S. Department of Justice |
| Publisher | : Lulu.com |
| Total Pages | : 88 |
| Release | : 2019-04-13 |
| Genre | : Reference |
| ISBN | : 035958828X |
The Drug Enforcement Administration is pleased to provide you with the 2010 edition of the Pharmacist's Manual to assist you in understanding the provisions of the Controlled Substances Act (CSA) and its implementing regulations. This manual will answer questions you may encounter in the practice of pharmacy and provide guidance in complying with the CSA regulations. This edition has been updated to include information on the provisions of the Combat Methamphetamine Epidemic Act of 2005, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, and the Interim Final Rule entitled Electronic Prescriptions for Controlled Substances. Your role in the proper dispensing of controlled substances is critical to the health of patients and helps protect society against drug abuse and diversion. Your adherence to the CSA, together with its objectives and your compliance, is a powerful resource for protecting the public health, assuring patient safety, and preventing the diversion of controlled substances and...
Remington
| Author | : David B. Troy |
| Publisher | : Lippincott Williams & Wilkins |
| Total Pages | : 2452 |
| Release | : 2006 |
| Genre | : Medical |
| ISBN | : 9780781746731 |
For over 100 years, Remington has been the definitive textbook and reference on the science and practice of pharmacy. This Twenty-First Edition keeps pace with recent changes in the pharmacy curriculum and professional pharmacy practice. More than 95 new contributors and 5 new section editors provide fresh perspectives on the field. New chapters include pharmacogenomics, application of ethical principles to practice dilemmas, technology and automation, professional communication, medication errors, re-engineering pharmacy practice, management of special risk medicines, specialization in pharmacy practice, disease state management, emergency patient care, and wound care. Purchasers of this textbook are entitled to a new, fully indexed Bonus CD-ROM, affording instant access to the full content of Remington in a convenient and portable format.
Meeting Accreditation Standards: A Pharmacy Preparation Guide
| Author | : John P Uselton |
| Publisher | : ASHP |
| Total Pages | : 757 |
| Release | : 2019-12-31 |
| Genre | : Medical |
| ISBN | : 1585284475 |
Meeting Accreditation Standards: A Pharmacy Preparation Guide is the only book to cover all the latest major accreditation standards. Highlights include: Major changes including revised survey processes and streamlined standards to emphasize CMS’s focus on safety and improving the quality of patient care New chapters for the fourth accreditation organization CIHQ, Antimicrobial Stewardship, and Pain Management Addresses the standards and requirements effective from July 2019 to the extent that they are known Contains the most up-to-date medication management (MM) standards and requirements and the medication-related 2019 NPSGs and their requirements
Pharmacy Practice and the Law
| Author | : Richard R. Abood |
| Publisher | : Jones & Bartlett Learning |
| Total Pages | : 408 |
| Release | : 2005 |
| Genre | : Law |
| ISBN | : 9780763747244 |
Pharmacy Practice and the Law creates a solid overview of pharmacy law, incorporating relevant case laws and historical backgrounds of why and how specific laws developed. The new Fourth Edition stimulates critical thinking issues in pharmacy law and explains the federal and state pharmacy regulation that corresponds to recent directives of the American Association of Colleges of Pharmacy. This text serves as a tool to pass the law portion of a board examination, and helps students develop as practitioners, contributors andleaders to the profession itself.
Pain Management and the Opioid Epidemic
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 483 |
| Release | : 2017-09-28 |
| Genre | : Medical |
| ISBN | : 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
